Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Walz

Showing results (121-130 of 212) with videos related to

Pageof 22
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 15, 2018
Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimenGwenaëlle Gravis, Emilien Billon, Capucine Baldini, et al.
European Urology Open Science|July 19, 2024
Cost Analysis of Prostate Cancer Care Using a Biomarker-enhanced Diagnostic Strategy with Stockholm3Olga Dianna McLeod, Thorgerdur Palsdottir, Jochen Walz, et al.
European Urology|February 7, 2016
A Critical Analysis of the Current Knowledge of Surgical Anatomy of the Prostate Related to Optimisation of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy: An UpdateJochen Walz, Jonathan I Epstein, Roman Ganzer, et al.
Clinical Genitourinary Cancer|April 14, 2021
Prognostic Risk Classification for Biochemical Relapse-Free Survival in Oligometastatic Recurrent Prostate Cancer Determined by Choline PETGwenaelle Gravis, Aurélie Autret, Morgane Guibert-Broudic, et al.
Minerva Urology and Nephrology|November 16, 2022
Impact of long-term indwelling JJ stent on renal volume and renal functionNicolas Branger, Vito Lorusso, Andrea Pacchetti, et al.
Cancer|February 21, 2008
A nomogram predicting long-term biochemical recurrence after radical prostatectomyNazareno Suardi, Christopher R Porter, Alwyn M Reuther, et al.
European Urology|December 19, 2006
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mLAndrea Gallina, Claudio Jeldres, Felix K-H Chun, et al.
European Journal of Cancer (Oxford, England : 1990)|February 13, 2007
Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screeningGeorg Hutterer, Paul Perrotte, Andrea Gallina, et al.
European Urology Oncology|April 2, 2019
A Systematic Review on the Role of Imaging in Early Recurrent Prostate CancerPieter J L De Visschere, Chloë Standaert, Jurgen J Fütterer, et al.
European Urology|July 13, 2010
External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcomeMarco Auprich, Alexander Haese, Jochen Walz, et al.
Pageof 22

Showing results (121-130 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|October 15, 2018
Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimenGwenaëlle Gravis, Emilien Billon, Capucine Baldini, et al.
European Urology Open Science|July 19, 2024
Cost Analysis of Prostate Cancer Care Using a Biomarker-enhanced Diagnostic Strategy with Stockholm3Olga Dianna McLeod, Thorgerdur Palsdottir, Jochen Walz, et al.
European Urology|February 7, 2016
A Critical Analysis of the Current Knowledge of Surgical Anatomy of the Prostate Related to Optimisation of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy: An UpdateJochen Walz, Jonathan I Epstein, Roman Ganzer, et al.
Clinical Genitourinary Cancer|April 14, 2021
Prognostic Risk Classification for Biochemical Relapse-Free Survival in Oligometastatic Recurrent Prostate Cancer Determined by Choline PETGwenaelle Gravis, Aurélie Autret, Morgane Guibert-Broudic, et al.
Minerva Urology and Nephrology|November 16, 2022
Impact of long-term indwelling JJ stent on renal volume and renal functionNicolas Branger, Vito Lorusso, Andrea Pacchetti, et al.
Cancer|February 21, 2008
A nomogram predicting long-term biochemical recurrence after radical prostatectomyNazareno Suardi, Christopher R Porter, Alwyn M Reuther, et al.
European Urology|December 19, 2006
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mLAndrea Gallina, Claudio Jeldres, Felix K-H Chun, et al.
European Journal of Cancer (Oxford, England : 1990)|February 13, 2007
Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screeningGeorg Hutterer, Paul Perrotte, Andrea Gallina, et al.
European Urology Oncology|April 2, 2019
A Systematic Review on the Role of Imaging in Early Recurrent Prostate CancerPieter J L De Visschere, Chloë Standaert, Jurgen J Fütterer, et al.
European Urology|July 13, 2010
External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcomeMarco Auprich, Alexander Haese, Jochen Walz, et al.
Pageof 22